Takeda Pharmaceutical Co., Ltd. (TAK)
16.04
-0.12
(-0.71%)
USD |
NYSE |
Jan 20, 10:07
Takeda Pharmaceutical Shareholders Equity (Quarterly): 48.28B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Novartis AG | 44.33B |
| Pfizer Inc. | 92.80B |
| Sanofi | -- |
| Nxera Pharma Co., Ltd. | 444.57M |
| Protagonist Therapeutics, Inc. | 645.44M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 97.98B |
| Total Liabilities (Quarterly) | 49.69B |
| Debt to Equity Ratio | 0.6515 |
| Current Ratio | 1.365 |
| Net Debt Paydown Yield | 1.13% |